Dr. Mmr Sunway Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 132.84%
- Profit Growth 19.47%
- Ebitda -48.92%
- Net Worth 64.15%
- Total Assets 160.96%
About Dr. Mmr Sunway Hospitals
Dr. Mmr Sunway Hospitals Private Limited (DMSHPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 March 2020 (Four years and 11 months 9 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Madan Munamala and Sameera Gaddam serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85300TN2020PTC134735
-
Company No.
134735
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Mar 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Dr. Mmr Sunway Hospitals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madan Munamala
|
Managing Director | 02-Mar-2020 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sameera Gaddam
|
Director | 02-Mar-2020 | Current |
Financial Performance of Dr. Mmr Sunway Hospitals.
Dr. Mmr Sunway Hospitals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 132.84% increase. The company also saw a substantial improvement in profitability, with a 19.47% increase in profit. The company's net worth Soared by an impressive increase of 64.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Mmr Sunway Hospitals?
Unlock access to Dr. Mmr Sunway Hospitals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sunway Medical Center Private LimitedMadan Munamala and Sameera Gaddam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. Mmr Sunway Hospitals?
Unlock and access historical data on people associated with Dr. Mmr Sunway Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Mmr Sunway Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Mmr Sunway Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.